Global Aprepitant Injection Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Aprepitant Injection market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Arepidan injection is a submicron emulsion prepared by wrapping Arepidan in soybean oil. Compared with oral preparation, it can significantly improve the bioavailability and drug compliance; At the same time, it can effectively reduce the incidence of anaphylaxis in the clinical use of similar injection preparations. It is a prescription drug for the treatment of nausea and vomiting caused by chemotherapy. It can be used alone or together with other drugs.
This report is a detailed and comprehensive analysis for global Aprepitant Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Aprepitant Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Aprepitant Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Aprepitant Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Aprepitant Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Aprepitant Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Aprepitant Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Heron Therapeutics, Inc., Qilu Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Aprepitant Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Injection
Injection Lotion
Market segment by Application
Cancer Treatment Center
Hospital
Major players covered
Heron Therapeutics, Inc.
Qilu Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Aprepitant Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Aprepitant Injection, with price, sales quantity, revenue, and global market share of Aprepitant Injection from 2020 to 2025.
Chapter 3, the Aprepitant Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Aprepitant Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Aprepitant Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Aprepitant Injection.
Chapter 14 and 15, to describe Aprepitant Injection sales channel, distributors, customers, research findings and conclusion.
Arepidan injection is a submicron emulsion prepared by wrapping Arepidan in soybean oil. Compared with oral preparation, it can significantly improve the bioavailability and drug compliance; At the same time, it can effectively reduce the incidence of anaphylaxis in the clinical use of similar injection preparations. It is a prescription drug for the treatment of nausea and vomiting caused by chemotherapy. It can be used alone or together with other drugs.
This report is a detailed and comprehensive analysis for global Aprepitant Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Aprepitant Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Aprepitant Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Aprepitant Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Aprepitant Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Aprepitant Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Aprepitant Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Heron Therapeutics, Inc., Qilu Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Aprepitant Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Injection
Injection Lotion
Market segment by Application
Cancer Treatment Center
Hospital
Major players covered
Heron Therapeutics, Inc.
Qilu Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Aprepitant Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Aprepitant Injection, with price, sales quantity, revenue, and global market share of Aprepitant Injection from 2020 to 2025.
Chapter 3, the Aprepitant Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Aprepitant Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Aprepitant Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Aprepitant Injection.
Chapter 14 and 15, to describe Aprepitant Injection sales channel, distributors, customers, research findings and conclusion.
Table of Contents
82 Pages
- 1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Aprepitant Injection Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Injection
- 1.3.3 Injection Lotion
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Aprepitant Injection Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Cancer Treatment Center
- 1.4.3 Hospital
- 1.5 Global Aprepitant Injection Market Size & Forecast
- 1.5.1 Global Aprepitant Injection Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Aprepitant Injection Sales Quantity (2020-2031)
- 1.5.3 Global Aprepitant Injection Average Price (2020-2031)
- 2 Manufacturers Profiles
- 2.1 Heron Therapeutics, Inc.
- 2.1.1 Heron Therapeutics, Inc. Details
- 2.1.2 Heron Therapeutics, Inc. Major Business
- 2.1.3 Heron Therapeutics, Inc. Aprepitant Injection Product and Services
- 2.1.4 Heron Therapeutics, Inc. Aprepitant Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Heron Therapeutics, Inc. Recent Developments/Updates
- 2.2 Qilu Pharmaceutical
- 2.2.1 Qilu Pharmaceutical Details
- 2.2.2 Qilu Pharmaceutical Major Business
- 2.2.3 Qilu Pharmaceutical Aprepitant Injection Product and Services
- 2.2.4 Qilu Pharmaceutical Aprepitant Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Qilu Pharmaceutical Recent Developments/Updates
- 3 Competitive Environment: Aprepitant Injection by Manufacturer
- 3.1 Global Aprepitant Injection Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Aprepitant Injection Revenue by Manufacturer (2020-2025)
- 3.3 Global Aprepitant Injection Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Aprepitant Injection by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Aprepitant Injection Manufacturer Market Share in 2024
- 3.4.3 Top 6 Aprepitant Injection Manufacturer Market Share in 2024
- 3.5 Aprepitant Injection Market: Overall Company Footprint Analysis
- 3.5.1 Aprepitant Injection Market: Region Footprint
- 3.5.2 Aprepitant Injection Market: Company Product Type Footprint
- 3.5.3 Aprepitant Injection Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
- 4 Consumption Analysis by Region
- 4.1 Global Aprepitant Injection Market Size by Region
- 4.1.1 Global Aprepitant Injection Sales Quantity by Region (2020-2031)
- 4.1.2 Global Aprepitant Injection Consumption Value by Region (2020-2031)
- 4.1.3 Global Aprepitant Injection Average Price by Region (2020-2031)
- 4.2 North America Aprepitant Injection Consumption Value (2020-2031)
- 4.3 Europe Aprepitant Injection Consumption Value (2020-2031)
- 4.4 Asia-Pacific Aprepitant Injection Consumption Value (2020-2031)
- 4.5 South America Aprepitant Injection Consumption Value (2020-2031)
- 4.6 Middle East & Africa Aprepitant Injection Consumption Value (2020-2031)
- 5 Market Segment by Type
- 5.1 Global Aprepitant Injection Sales Quantity by Type (2020-2031)
- 5.2 Global Aprepitant Injection Consumption Value by Type (2020-2031)
- 5.3 Global Aprepitant Injection Average Price by Type (2020-2031)
- 6 Market Segment by Application
- 6.1 Global Aprepitant Injection Sales Quantity by Application (2020-2031)
- 6.2 Global Aprepitant Injection Consumption Value by Application (2020-2031)
- 6.3 Global Aprepitant Injection Average Price by Application (2020-2031)
- 7 North America
- 7.1 North America Aprepitant Injection Sales Quantity by Type (2020-2031)
- 7.2 North America Aprepitant Injection Sales Quantity by Application (2020-2031)
- 7.3 North America Aprepitant Injection Market Size by Country
- 7.3.1 North America Aprepitant Injection Sales Quantity by Country (2020-2031)
- 7.3.2 North America Aprepitant Injection Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
- 8 Europe
- 8.1 Europe Aprepitant Injection Sales Quantity by Type (2020-2031)
- 8.2 Europe Aprepitant Injection Sales Quantity by Application (2020-2031)
- 8.3 Europe Aprepitant Injection Market Size by Country
- 8.3.1 Europe Aprepitant Injection Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Aprepitant Injection Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
- 9 Asia-Pacific
- 9.1 Asia-Pacific Aprepitant Injection Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Aprepitant Injection Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Aprepitant Injection Market Size by Region
- 9.3.1 Asia-Pacific Aprepitant Injection Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Aprepitant Injection Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
- 10 South America
- 10.1 South America Aprepitant Injection Sales Quantity by Type (2020-2031)
- 10.2 South America Aprepitant Injection Sales Quantity by Application (2020-2031)
- 10.3 South America Aprepitant Injection Market Size by Country
- 10.3.1 South America Aprepitant Injection Sales Quantity by Country (2020-2031)
- 10.3.2 South America Aprepitant Injection Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
- 11 Middle East & Africa
- 11.1 Middle East & Africa Aprepitant Injection Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Aprepitant Injection Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Aprepitant Injection Market Size by Country
- 11.3.1 Middle East & Africa Aprepitant Injection Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Aprepitant Injection Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
- 12 Market Dynamics
- 12.1 Aprepitant Injection Market Drivers
- 12.2 Aprepitant Injection Market Restraints
- 12.3 Aprepitant Injection Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 13 Raw Material and Industry Chain
- 13.1 Raw Material of Aprepitant Injection and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Aprepitant Injection
- 13.3 Aprepitant Injection Production Process
- 13.4 Industry Value Chain Analysis
- 14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Aprepitant Injection Typical Distributors
- 14.3 Aprepitant Injection Typical Customers
- 15 Research Findings and Conclusion
- 16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
- 16.3 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
